To determine the critical role of HDAC2 in AML, we detected the HDAC2 expression in 77 AML patients and 72 healthy donors by RT-qPCR and found that HDAC2 was highly expressed in patients (Fig. 7B). This evidence concerns the gene HDAC2 and acute myeloid leukemia.